Elicio Therapeutics
IPOElicio Therapeutics is a biotech company in Boston, United States. It has raised $45.6M across 3 rounds, most recently a $10.0M Venture Round in June 2025.
Lymph Node-Targeted Immunotherapies
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- elicio.com
- Total Funding
- $45.6M
- Last Round
- $10.0M Venture RoundJun 2025
- Rounds
- 3
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.
About
Biotech company developing lymph node-targeted AMP-powered immunotherapies for cancer treatment.
Summary
It lists 11–50 employees. It has raised $45.6M in total across 3 rounds, most recently a $10.0M Venture Round in Jun 2025. Investors include Gastro-Intestinal Research Foundation and Livzon Pharmaceutical Group.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2025
Sign up to see all 3 events
Funding: Series B through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/elicio-therapeutics"><img src="https://indexed.vc/api/badge/company/elicio-therapeutics" alt="Elicio Therapeutics on Indexed.vc" width="260" height="76" /></a>